Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Cancer Stem Cells: Notes for Authors.

Eaves CJ, Pera MF.

Stem Cell Reports. 2020 Feb 11;14(2):167-168. doi: 10.1016/j.stemcr.2020.01.011.

2.

Toward Guidelines for Research on Human Embryo Models Formed from Stem Cells.

Hyun I, Munsie M, Pera MF, Rivron NC, Rossant J.

Stem Cell Reports. 2020 Feb 11;14(2):169-174. doi: 10.1016/j.stemcr.2019.12.008. Epub 2020 Jan 16.

3.

Antibodies to a CA 19-9 Related Antigen Complex Identify SOX9 Expressing Progenitor Cells In Human Foetal Pancreas and Pancreatic Adenocarcinoma.

Farley AM, Braxton DR, Li J, Trounson K, Sakar-Dey S, Nayer B, Ikeda T, Lau KX, Hardikar W, Hasegawa K, Pera MF.

Sci Rep. 2019 Feb 27;9(1):2876. doi: 10.1038/s41598-019-38988-8.

4.

Dietary Diversity, Food Security, and Body Image among Women and Children on San Cristobal Island, Galapagos.

Pera MF, Katz BNH, Bentley ME.

Matern Child Health J. 2019 Jun;23(6):830-838. doi: 10.1007/s10995-018-02701-4.

PMID:
30689143
5.

Capturing Totipotent Stem Cells.

Baker CL, Pera MF.

Cell Stem Cell. 2018 Jan 4;22(1):25-34. doi: 10.1016/j.stem.2017.12.011. Review.

6.

Erratum: Revisiting the Warnock rule.

Hurlbut JB, Hyun I, Levine AD, Lovell-Badge R, Lunshof JE, Matthews KRW, Mills P, Murdoch A, Pera MF, Scott CT, Tizzard J, Warnock M, Zernicka-Goetz M, Zhou Q, Zoloth L.

Nat Biotechnol. 2017 Dec 8;35(12):1211. doi: 10.1038/nbt1217-1211d.

PMID:
29220028
7.

Revisiting the Warnock rule.

Hurlbut JB, Hyun I, Levine AD, Lovell-Badge R, Lunshof JE, Matthews KRW, Mills P, Murdoch A, Pera MF, Scott CT, Tizzard J, Warnock M, Zernicka-Goetz M, Zhou Q, Zoloth L.

Nat Biotechnol. 2017 Nov 9;35(11):1029-1042. doi: 10.1038/nbt.4015. No abstract available. Erratum in: Nat Biotechnol. 2017 Dec 8;35(12 ):1211.

PMID:
29121021
8.

Method of derivation and differentiation of mouse embryonic stem cells generating synchronous neuronal networks.

Gazina EV, Morrisroe E, Mendis GDC, Michalska AE, Chen J, Nefzger CM, Rollo BN, Reid CA, Pera MF, Petrou S.

J Neurosci Methods. 2018 Jan 1;293:53-58. doi: 10.1016/j.jneumeth.2017.08.018. Epub 2017 Aug 18.

PMID:
28827162
9.

Friedreich's ataxia induced pluripotent stem cell-derived cardiomyocytes display electrophysiological abnormalities and calcium handling deficiency.

Crombie DE, Curl CL, Raaijmakers AJ, Sivakumaran P, Kulkarni T, Wong RC, Minami I, Evans-Galea MV, Lim SY, Delbridge L, Corben LA, Dottori M, Nakatsuji N, Trounce IA, Hewitt AW, Delatycki MB, Pera MF, Pébay A.

Aging (Albany NY). 2017 May 30;9(5):1440-1452. doi: 10.18632/aging.101247.

10.

Human embryo research and the 14-day rule.

Pera MF.

Development. 2017 Jun 1;144(11):1923-1925. doi: 10.1242/dev.151191. Review.

11.

Maintenance of Human Embryonic Stem Cells by Sphingosine-1-Phosphate and Platelet-Derived Growth Factor.

Wong RCB, Pera MF, Pébay A.

Methods Mol Biol. 2018;1697:133-140. doi: 10.1007/7651_2017_4.

PMID:
28324485
12.

Stem Cell Surface Marker Expression Defines Late Stages of Reprogramming to Pluripotency in Human Fibroblasts.

Pomeroy JE, Hough SR, Davidson KC, Quaas AM, Rees JA, Pera MF.

Stem Cells Transl Med. 2016 Jul;5(7):870-82. doi: 10.5966/sctm.2015-0250. Epub 2016 May 9.

13.

Using human pluripotent stem cells to study Friedreich ataxia cardiomyopathy.

Crombie DE, Pera MF, Delatycki MB, Pébay A.

Int J Cardiol. 2016 Jun 1;212:37-43. doi: 10.1016/j.ijcard.2016.03.040. Epub 2016 Mar 21. Review.

PMID:
27019046
14.

What if stem cells turn into embryos in a dish?

Pera MF, de Wert G, Dondorp W, Lovell-Badge R, Mummery CL, Munsie M, Tam PP.

Nat Methods. 2015 Oct;12(10):917-9. doi: 10.1038/nmeth.3586.

PMID:
26418764
15.

The pluripotent state in mouse and human.

Davidson KC, Mason EA, Pera MF.

Development. 2015 Sep 15;142(18):3090-9. doi: 10.1242/dev.116061. Review.

16.

Characterization of the retinal pigment epithelium in Friedreich ataxia.

Crombie DE, Van Bergen N, Davidson KC, Anjomani Virmouni S, Mckelvie PA, Chrysostomou V, Conquest A, Corben LA, Pook MA, Kulkarni T, Trounce IA, Pera MF, Delatycki MB, Pébay A.

Biochem Biophys Rep. 2015 Sep 11;4:141-147. doi: 10.1016/j.bbrep.2015.09.003. eCollection 2015 Dec.

17.

Multipotent caudal neural progenitors derived from human pluripotent stem cells that give rise to lineages of the central and peripheral nervous system.

Denham M, Hasegawa K, Menheniott T, Rollo B, Zhang D, Hough S, Alshawaf A, Febbraro F, Ighaniyan S, Leung J, Elliott DA, Newgreen DF, Pera MF, Dottori M.

Stem Cells. 2015 Jun;33(6):1759-70. doi: 10.1002/stem.1991.

18.

In search of naivety.

Pera MF.

Cell Stem Cell. 2014 Nov 6;15(5):543-5. doi: 10.1016/j.stem.2014.10.013. Epub 2014 Nov 6.

19.

Gene expression variability as a unifying element of the pluripotency network.

Mason EA, Mar JC, Laslett AL, Pera MF, Quackenbush J, Wolvetang E, Wells CA.

Stem Cell Reports. 2014 Aug 12;3(2):365-77. doi: 10.1016/j.stemcr.2014.06.008. Epub 2014 Jul 25.

20.

Single-cell gene expression profiles define self-renewing, pluripotent, and lineage primed states of human pluripotent stem cells.

Hough SR, Thornton M, Mason E, Mar JC, Wells CA, Pera MF.

Stem Cell Reports. 2014 May 22;2(6):881-95. doi: 10.1016/j.stemcr.2014.04.014. eCollection 2014 Jun 3.

21.

Human pluripotent stem cell strategies for age-related macular degeneration.

Davidson KC, Guymer RH, Pera MF, Pébay A.

Optom Vis Sci. 2014 Aug;91(8):887-93. doi: 10.1097/OPX.0000000000000282. Review.

PMID:
24859130
22.

Stress management: a new path to pluripotency.

Pera MF.

Cell Stem Cell. 2014 Mar 6;14(3):273-4. doi: 10.1016/j.stem.2014.02.009.

23.

BCL-XL mediates the strong selective advantage of a 20q11.21 amplification commonly found in human embryonic stem cell cultures.

Avery S, Hirst AJ, Baker D, Lim CY, Alagaratnam S, Skotheim RI, Lothe RA, Pera MF, Colman A, Robson P, Andrews PW, Knowles BB.

Stem Cell Reports. 2013 Oct 31;1(5):379-86. doi: 10.1016/j.stemcr.2013.10.005. eCollection 2013.

24.

Epigenetics, vitamin supplements and cellular reprogramming.

Pera MF.

Nat Genet. 2013 Dec;45(12):1412-3. doi: 10.1038/ng.2834.

PMID:
24270443
25.

Stem cell science and regenerative medicine.

Tam PP, Pera MF.

Bioessays. 2013 Mar;35(3):147-8. doi: 10.1002/bies.201300003. No abstract available.

PMID:
23401027
26.

Wnt signaling orchestration with a small molecule DYRK inhibitor provides long-term xeno-free human pluripotent cell expansion.

Hasegawa K, Yasuda SY, Teo JL, Nguyen C, McMillan M, Hsieh CL, Suemori H, Nakatsuji N, Yamamoto M, Miyabayashi T, Lutzko C, Pera MF, Kahn M.

Stem Cells Transl Med. 2012 Jan;1(1):18-28. doi: 10.5966/sctm.2011-0033. Epub 2011 Dec 7.

27.

Cell reprogramming.

Pera MF, Plath K.

Curr Opin Genet Dev. 2012 Oct;22(5):401-2. doi: 10.1016/j.gde.2012.10.001. Epub 2012 Oct 18. No abstract available.

PMID:
23084811
28.

Lessons from human teratomas to guide development of safe stem cell therapies.

Cunningham JJ, Ulbright TM, Pera MF, Looijenga LH.

Nat Biotechnol. 2012 Sep;30(9):849-57. Review.

PMID:
22965062
29.

The GCTM-5 epitope associated with the mucin-like glycoprotein FCGBP marks progenitor cells in tissues of endodermal origin.

Stamp LA, Braxton DR, Wu J, Akopian V, Hasegawa K, Chandrasoma PT, Hawes SM, McLean C, Petrovic LM, Wang K, Pera MF.

Stem Cells. 2012 Sep;30(9):1999-2009. doi: 10.1002/stem.1167.

30.

Maintenance of human embryonic stem cells by sphingosine-1-phosphate and platelet-derived growth factor.

Wong RC, Pera MF, Pébay A.

Methods Mol Biol. 2012;874:167-75. doi: 10.1007/978-1-61779-800-9_13.

PMID:
22528447
31.

Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage.

International Stem Cell Initiative, Amps K, Andrews PW, Anyfantis G, Armstrong L, Avery S, Baharvand H, Baker J, Baker D, Munoz MB, Beil S, Benvenisty N, Ben-Yosef D, Biancotti JC, Bosman A, Brena RM, Brison D, Caisander G, Camarasa MV, Chen J, Chiao E, Choi YM, Choo AB, Collins D, Colman A, Crook JM, Daley GQ, Dalton A, De Sousa PA, Denning C, Downie J, Dvorak P, Montgomery KD, Feki A, Ford A, Fox V, Fraga AM, Frumkin T, Ge L, Gokhale PJ, Golan-Lev T, Gourabi H, Gropp M, Lu G, Hampl A, Harron K, Healy L, Herath W, Holm F, Hovatta O, Hyllner J, Inamdar MS, Irwanto AK, Ishii T, Jaconi M, Jin Y, Kimber S, Kiselev S, Knowles BB, Kopper O, Kukharenko V, Kuliev A, Lagarkova MA, Laird PW, Lako M, Laslett AL, Lavon N, Lee DR, Lee JE, Li C, Lim LS, Ludwig TE, Ma Y, Maltby E, Mateizel I, Mayshar Y, Mileikovsky M, Minger SL, Miyazaki T, Moon SY, Moore H, Mummery C, Nagy A, Nakatsuji N, Narwani K, Oh SK, Oh SK, Olson C, Otonkoski T, Pan F, Park IH, Pells S, Pera MF, Pereira LV, Qi O, Raj GS, Reubinoff B, Robins A, Robson P, Rossant J, Salekdeh GH, Schulz TC, Sermon K, Sheik Mohamed J, Shen H, Sherrer E, Sidhu K, Sivarajah S, Skottman H, Spits C, Stacey GN, Strehl R, Strelchenko N, Suemori H, Sun B, Suuronen R, Takahashi K, Tuuri T, Venu P, Verlinsky Y, Ward-van Oostwaard D, Weisenberger DJ, Wu Y, Yamanaka S, Young L, Zhou Q.

Nat Biotechnol. 2011 Nov 27;29(12):1132-44. doi: 10.1038/nbt.2051.

32.

The proteomes of native and induced pluripotent stem cells.

Pera MF.

Nat Methods. 2011 Sep 29;8(10):807-8. doi: 10.1038/nmeth.1707. No abstract available.

PMID:
21959134
33.

Stem cells: The dark side of induced pluripotency.

Pera MF.

Nature. 2011 Mar 3;471(7336):46-7. doi: 10.1038/471046a. No abstract available.

PMID:
21368819
34.

Safely modulating the immune system in regenerative medicine.

Pera MF.

Cell Stem Cell. 2011 Mar 4;8(3):246-7. doi: 10.1016/j.stem.2011.02.013.

35.

Defining pluripotency.

Pera MF.

Nat Methods. 2010 Nov;7(11):885-7. doi: 10.1038/nmeth1110-885.

PMID:
21030963
36.

Ascorbate promotes epigenetic activation of CD30 in human embryonic stem cells.

Chung TL, Turner JP, Thaker NY, Kolle G, Cooper-White JJ, Grimmond SM, Pera MF, Wolvetang EJ.

Stem Cells. 2010 Oct;28(10):1782-93. doi: 10.1002/stem.500.

37.

Vitamin C promotes widespread yet specific DNA demethylation of the epigenome in human embryonic stem cells.

Chung TL, Brena RM, Kolle G, Grimmond SM, Berman BP, Laird PW, Pera MF, Wolvetang EJ.

Stem Cells. 2010 Oct;28(10):1848-55. doi: 10.1002/stem.493.

38.

Comparison of reprogramming efficiency between transduction of reprogramming factors, cell-cell fusion, and cytoplast fusion.

Hasegawa K, Zhang P, Wei Z, Pomeroy JE, Lu W, Pera MF.

Stem Cells. 2010 Aug;28(8):1338-48. doi: 10.1002/stem.466.

39.

Current technology for the derivation of pluripotent stem cell lines from human embryos.

Hasegawa K, Pomeroy JE, Pera MF.

Cell Stem Cell. 2010 Jun 4;6(6):521-31. doi: 10.1016/j.stem.2010.05.010.

40.

Extrinsic regulation of pluripotent stem cells.

Pera MF, Tam PP.

Nature. 2010 Jun 10;465(7299):713-20. doi: 10.1038/nature09228. Review.

PMID:
20535200
41.

Comparison of transplant efficiency between spontaneously derived and noggin-primed human embryonic stem cell neural precursors in the quinolinic acid rat model of Huntington's disease.

Vazey EM, Dottori M, Jamshidi P, Tomas D, Pera MF, Horne M, Connor B.

Cell Transplant. 2010;19(8):1055-62. doi: 10.3727/096368910X494632. Epub 2010 Mar 26.

PMID:
20350346
42.

Human ES cell lines--introduction.

Andrews PW, Benvenisty N, Knowles BB, McKay RD, Oh SK, Pera MF, Rossant J, Stacey GN.

In Vitro Cell Dev Biol Anim. 2010 Apr;46(3-4):167-8. doi: 10.1007/s11626-010-9306-2. Epub 2010 Mar 7. No abstract available.

PMID:
20213278
43.

Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells.

International Stem Cell Initiative Consortium, Akopian V, Andrews PW, Beil S, Benvenisty N, Brehm J, Christie M, Ford A, Fox V, Gokhale PJ, Healy L, Holm F, Hovatta O, Knowles BB, Ludwig TE, McKay RD, Miyazaki T, Nakatsuji N, Oh SK, Pera MF, Rossant J, Stacey GN, Suemori H.

In Vitro Cell Dev Biol Anim. 2010 Apr;46(3-4):247-58. doi: 10.1007/s11626-010-9297-z. Epub 2010 Feb 26.

44.

Subfractionation of differentiating human embryonic stem cell populations allows the isolation of a mesodermal population enriched for intermediate mesoderm and putative renal progenitors.

Lin SA, Kolle G, Grimmond SM, Zhou Q, Doust E, Little MH, Aronow B, Ricardo SD, Pera MF, Bertram JF, Laslett AL.

Stem Cells Dev. 2010 Oct;19(10):1637-48. doi: 10.1089/scd.2010.0017.

45.

A continuum of cell states spans pluripotency and lineage commitment in human embryonic stem cells.

Hough SR, Laslett AL, Grimmond SB, Kolle G, Pera MF.

PLoS One. 2009 Nov 5;4(11):e7708. doi: 10.1371/journal.pone.0007708.

46.

BMP-11 and myostatin support undifferentiated growth of human embryonic stem cells in feeder-free cultures.

Hannan NR, Jamshidi P, Pera MF, Wolvetang EJ.

Cloning Stem Cells. 2009 Sep;11(3):427-35. doi: 10.1089/clo.2009.0024.

PMID:
19751112
47.

Stem cells: Low-risk reprogramming.

Pera MF.

Nature. 2009 Apr 9;458(7239):715-6. doi: 10.1038/458715a. No abstract available.

PMID:
19360075
48.

Acute effect of endothelins on intercellular communication of human embryonic stem cells.

Wong RC, Davidson KC, Leung J, Pera MF, Pébay A.

J Stem Cells. 2009;4(1):47-56. doi: jsc.2009.4.1.47.

PMID:
20498690
49.

Germline competent embryonic stem cells derived from rat blastocysts.

Li P, Tong C, Mehrian-Shai R, Jia L, Wu N, Yan Y, Maxson RE, Schulze EN, Song H, Hsieh CL, Pera MF, Ying QL.

Cell. 2008 Dec 26;135(7):1299-310. doi: 10.1016/j.cell.2008.12.006.

50.

Role of gap junctions in embryonic and somatic stem cells.

Wong RC, Pera MF, Pébay A.

Stem Cell Rev. 2008 Dec;4(4):283-92. doi: 10.1007/s12015-008-9038-9. Review.

PMID:
18704771

Supplemental Content

Support Center